v3.25.2
Summary of Significant Accounting Policies (Details)
6 Months Ended 12 Months Ended
Feb. 11, 2020
Jun. 30, 2025
segment
noncontrolling_interest
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Number of noncontrolling interests created | noncontrolling_interest   4      
Number of reportable segments | segment   1      
Vertex | Current Portion of Financial Royalty Assets | Customer Concentration Risk          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Individual licensees exceeding 10% or more of revenue (as percent)   31.00% 34.00%    
RPCT          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Ownership percentage (as a percent) 66.00%        
Royalty Pharma Investments          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Ownership percentage (as a percent)         82.00%
Legacy Investors Partnerships | Old RPI          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Noncontrolling interest (as percent)   18.00%      
Exchange Offer Transaction | Old RPI          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Ownership percentage (as a percent) 82.00%        
Exchange Offer Transaction | Royalty Pharma Select Finance Trust          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Ownership percentage (as a percent)       34.00%  
Exchange Offer Transaction | Legacy Investors Partnerships          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Exchange offering, ownership percentage (as a percent) 82.00%